Rachel Clingan has been working in the field of Palliative Medicine since December 2019, starting as a CT2 Doctor at LOROS Hospice. Rachel then progressed to a Trust Grade IMT3/ST3 Doctor at University Hospitals of Leicester NHS Trust before becoming an ST4 Doctor at various hospices and NHS Foundation Trusts. Rachel completed their medical education at Imperial College London and the University of Cambridge, specializing in Biological and Biomedical Sciences and Preclinical Medical Sciences.
October, 2022 - present
Director Of Corporate Communications, International at Pegasystems
Global Head Of Learning & Development at Clearwater Analytics
Corporate Vice President at Microsoft
Vice President Quality Assurance at Aldeyra Therapeutics
Managing Director - Macro Trading Risk Management at Morgan Stanley
Access the worlds's biggest network of public org charts
Learn more